SEATTLE, Feb. 25, 2026 /PRNewswire/ -- Valant, the leading provider of behavioral health EHR software, today announced expanded capabilities for its AI-powered clinical documentation tool, AI Notes ...
Several new guidance documents issued by the FDA are poised to significantly impact the rare disease development landscape.
Good afternoon, everyone, and welcome to the Caris Life Sciences Q4 2025 Earnings Call. My name is Dana, and I will be your coordinator today. Thank you. Earlier today, Caris Life Sciences released ...
This afternoon, we released financial results for the quarter and full year ended December 31, 2025, and recent corporate updates. The press release is available on the Investors section of our ...
Hybrid human–AI models emerge as the most viable approach. In such systems, AI handles low-risk, high-frequency tasks such as ...
FDA Approval for Pediatric Indication -- LINZESS received U.S. FDA approval in November 2025 for IBS-C patients aged 7-17, ...
Age related macular degeneration is diagnosed through eye examination. Ophthalmologists use retinal imaging and optical ...
Market set for 11.6% CAGR driven by sustainability push and circular economy adoption in medical device manufacturing - ...
Veru Inc. (NASDAQ:VERU) Q1 2026 Earnings Call Transcript February 11, 2026 Veru Inc. beats earnings expectations. Reported EPS is $-0.26254, expectations were $-0.47. Operator: Good morning, ladies ...
Thank you for joining our first quarter fiscal year 2026 earnings call. Veru Inc. is a late clinical-stage biopharmaceutical company focused on developing novel medicines for the treatment of ...
The Zen Parent on MSN
Feel like you're behind in life? You're not alone
Sure, you've hit your own milestones. Maybe you're in a career you love, secured your dream job, live in a cozy nook you can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results